Researcher.Life Logo

The Lancet Gastroenterology and Hepatology : Impact Factor & More

eISSN: 2468-1253pISSN: 2468-1253

Key Metrics

CiteScore
31
Scite Index
0.86 5-Year SI
SNIP
6.95
Recommended pre-submission checks
Powered by Paperpal by Editage

The Lancet Gastroenterology and Hepatology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2016
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in The Lancet Gastroenterology and Hepatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in The Lancet Gastroenterology and Hepatology

The burden of chronic hepatitis B and C in 2022 and progress towards elimination: a global report.
  • 1 Jun 2026
  • The lancet. Gastroenterology & hepatology
The challenge of defining metabolic dysfunction and alcohol-associated liver disease.
  • 1 Jun 2026
  • The lancet. Gastroenterology & hepatology
Infected for Science.
  • 1 Jun 2026
  • The lancet. Gastroenterology & hepatology
Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial.
  • 1 Jun 2026
  • The lancet. Gastroenterology & hepatology
Shared principles within HBV guidelines: aligning clinical approach with differentiated care for global elimination.
  • 1 Jun 2026
  • The lancet. Gastroenterology & hepatology
Rifaximin in cirrhosis: when therapeutic drift meets antimicrobial stewardship.
  • 1 Jun 2026
  • The lancet. Gastroenterology & hepatology
The burden of chronic hepatitis B and C in 2022 and progress towards elimination: a global report.
  • 1 Jun 2026
  • The lancet. Gastroenterology & hepatology
The challenge of defining metabolic dysfunction and alcohol-associated liver disease.
  • 1 Jun 2026
  • The lancet. Gastroenterology & hepatology
Infected for Science.
  • 1 Jun 2026
  • The lancet. Gastroenterology & hepatology
Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial.
  • 1 Jun 2026
  • The lancet. Gastroenterology & hepatology
Shared principles within HBV guidelines: aligning clinical approach with differentiated care for global elimination.
  • 1 Jun 2026
  • The lancet. Gastroenterology & hepatology
Rifaximin in cirrhosis: when therapeutic drift meets antimicrobial stewardship.
  • 1 Jun 2026
  • The lancet. Gastroenterology & hepatology

FAQs on The Lancet Gastroenterology and Hepatology